[{"id": "a5ac71f0d8588973a2de6418ffb434a7", "cik": "899923", "ticker": "MYGN", "name": "Paul J. Diaz", "position": "President and Chief Executive Officer 2020 Transition Period", "year": 2021, "salary": 1000000, "bonus": 500000, "stockAwards": 9869920, "optionAwards": 0, "nonEquityIncentiveCompensation": 1279000, "otherCompensation": 138749, "total": 12787669}, {"id": "7ca708de14a52e4afb9a0b0a692754d4", "cik": "899923", "ticker": "MYGN", "name": "Nicole Lambert", "position": "Chief Operating Officer 2020 Transition Period", "year": 2021, "salary": 475250, "bonus": 0, "stockAwards": 2086457, "optionAwards": 0, "nonEquityIncentiveCompensation": 336192, "otherCompensation": 13785, "total": 2911684}, {"id": "2fe9a3809e328c85c31d2da1801600fe", "cik": "899923", "ticker": "MYGN", "name": "R. Bryan Riggsbee", "position": "Chief Financial Officer and Treasurer 2020 Transition Period", "year": 2021, "salary": 526451, "bonus": 0, "stockAwards": 2022772, "optionAwards": 0, "nonEquityIncentiveCompensation": 394207, "otherCompensation": 13831, "total": 2957261}, {"id": "f49bb10ec91747e45985b2701fe502c7", "cik": "899923", "ticker": "MYGN", "name": "Mark Verratti", "position": "Chief Commercial Officer 2020 Transition Period", "year": 2021, "salary": 434489, "bonus": 0, "stockAwards": 1292885, "optionAwards": 0, "nonEquityIncentiveCompensation": 275032, "otherCompensation": 13769, "total": 2016175}, {"id": "d1dc695e94bb8ccf43860c295c288994", "cik": "899923", "ticker": "MYGN", "name": "Jerry S. Lanchbury, Ph.D.", "position": "Former Chief Scientific Officer 2020 Transition Period", "year": 2021, "salary": 544820, "bonus": 0, "stockAwards": 1194063, "optionAwards": 0, "nonEquityIncentiveCompensation": 294202, "otherCompensation": 13816, "total": 2046901}, {"id": "5fd16a1ba43448ea756b8ea5344ae0dd", "cik": "899923", "ticker": "MYGN", "name": "Paul J. Diaz President and Chief Executive Officer", "position": "", "year": 2020, "salary": 382663, "bonus": 0, "stockAwards": 8394628, "optionAwards": 5500006, "nonEquityIncentiveCompensation": 682000, "changeInPensionValueAndDeferredEarnings": 0, "otherCompensation": 541524, "total": 15500821}, {"id": "39b14fc2d23b49a2231a9142a4b466a7", "cik": "899923", "ticker": "MYGN", "name": "Jerry S. Lanchbury, Ph.D.", "position": "Chief Scientific Officer", "year": 2020, "salary": 493496, "bonus": 0, "stockAwards": 0, "optionAwards": 131599, "nonEquityIncentiveCompensation": 6943, "changeInPensionValueAndDeferredEarnings": 0, "otherCompensation": 0, "total": 1829238}, {"id": "dc5a8fa1cc43f2334a3b71006249458e", "cik": "899923", "ticker": "MYGN", "name": "R. Bryan Riggsbee", "position": "Chief Financial Officer and Treasurer 2020 Transition Period", "year": 2020, "salary": 552796, "bonus": 3461500, "stockAwards": 0, "optionAwards": 180209, "nonEquityIncentiveCompensation": 8836, "otherCompensation": 0, "total": 4203341}, {"id": "531d2ea7738b843ff224d38bbb4a1505", "cik": "899923", "ticker": "MYGN", "name": "Mark Verratti Group President of Myriad Neuroscience and Autoimmune", "position": "", "year": 2020, "salary": 204651, "bonus": 0, "stockAwards": 879288, "optionAwards": 0, "nonEquityIncentiveCompensation": 143273, "changeInPensionValueAndDeferredEarnings": 0, "otherCompensation": 8123, "total": 1235335}, {"id": "a0f60f8a3764674aed07ae61c653f6e1", "cik": "899923", "ticker": "MYGN", "name": "R. Bryan Riggsbee Chief Financial Officer and Treasurer Interim President and Chief Executive Officer", "position": "", "year": 2020, "salary": 552796, "bonus": 0, "stockAwards": 0, "optionAwards": 180209, "nonEquityIncentiveCompensation": 8836, "changeInPensionValueAndDeferredEarnings": 0, "otherCompensation": 0, "total": 4203341}, {"id": "5b9dd0de0b9cccd2dbc00693173f032d", "cik": "899923", "ticker": "MYGN", "name": "Nicole Lambert", "position": "Group President of Myriad Women\u2019s Health, Oncology, and International", "year": 2020, "salary": 386859, "bonus": 0, "stockAwards": 0, "optionAwards": 99934, "nonEquityIncentiveCompensation": 20713, "changeInPensionValueAndDeferredEarnings": 0, "otherCompensation": 0, "total": 1704706}, {"id": "dfce8ab548ddeb0333ae741c30cedc7d", "cik": "899923", "ticker": "MYGN", "name": "R. Bryan Riggsbee Chief Financial Officer and Treasurer Interim President and Chief Executive Officer", "position": "", "year": 2019, "salary": 466650, "bonus": 0, "stockAwards": 0, "optionAwards": 260671, "nonEquityIncentiveCompensation": 19162, "changeInPensionValueAndDeferredEarnings": 0, "otherCompensation": 0, "total": 3138983}, {"id": "88ff658e09a31a0b94d07208aef31eb1", "cik": "899923", "ticker": "MYGN", "name": "Alexander Ford", "position": "President, Myriad Genetic Laboratories", "year": 2019, "salary": 519168, "bonus": 200, "stockAwards": 2392500, "optionAwards": 0, "nonEquityIncentiveCompensation": 293226, "otherCompensation": 26608, "total": 3231702}, {"id": "222854791dbddec57d2194c33d81a202", "cik": "899923", "ticker": "MYGN", "name": "R. Bryan Riggsbee", "position": "Chief Financial Officer and Treasurer", "year": 2019, "salary": 466650, "bonus": 200, "stockAwards": 2392500, "optionAwards": 0, "nonEquityIncentiveCompensation": 260671, "otherCompensation": 18962, "total": 3138983}, {"id": "c7ef390cbc483ad1b2fb04f7b29331e3", "cik": "899923", "ticker": "MYGN", "name": "Richard M. Marsh, Esq.", "position": "Executive Vice President, General Counsel and Secretary", "year": 2019, "salary": 508595, "bonus": 200, "stockAwards": 1914000, "optionAwards": 0, "nonEquityIncentiveCompensation": 231919, "otherCompensation": 12687, "total": 2667401}, {"id": "7f3abfcf11e0f592af83f490223b380c", "cik": "899923", "ticker": "MYGN", "name": "Mark C. Capone", "position": "President and Chief Executive Officer and Director", "year": 2019, "salary": 887000, "bonus": 200, "stockAwards": 7177500, "optionAwards": 0, "nonEquityIncentiveCompensation": 802735, "otherCompensation": 29249, "total": 8896684}, {"id": "4ca63d328440ac048e480cf1fd4dfe81", "cik": "899923", "ticker": "MYGN", "name": "Jerry S. Lanchbury, Ph.D.", "position": "Chief Scientific Officer", "year": 2019, "salary": 508595, "bonus": 200, "stockAwards": 1914000, "optionAwards": 0, "nonEquityIncentiveCompensation": 250228, "otherCompensation": 12727, "total": 2685750}, {"id": "e3cb10900edd926dd4c67cae65a307c9", "cik": "899923", "ticker": "MYGN", "name": "Richard M. Marsh, Esq.", "position": "Executive VP, General Counsel & Secretary", "year": 2018, "salary": 493782, "bonus": 0, "stockAwards": 1628500, "optionAwards": 0, "nonEquityIncentiveCompensation": 234546, "otherCompensation": 10973, "total": 2367801}, {"id": "64711ed53dd63fdc18b7b4e9414fec5f", "cik": "899923", "ticker": "MYGN", "name": "Mark C. Capone", "position": "President and Chief Executive Officer*", "year": 2018, "salary": 852000, "bonus": 0, "stockAwards": 5374050, "optionAwards": 0, "nonEquityIncentiveCompensation": 817920, "otherCompensation": 10980, "total": 7054950}, {"id": "5bb77da3d6068590ee270b5145ffee32", "cik": "899923", "ticker": "MYGN", "name": "Jerry S. Lanchbury, Ph.D.", "position": "Chief Scientific Officer", "year": 2018, "salary": 493782, "bonus": 0, "stockAwards": 1628500, "optionAwards": 0, "nonEquityIncentiveCompensation": 244422, "otherCompensation": 10972, "total": 2377676}, {"id": "36970295fa37d4b782d250450c2f8b8e", "cik": "899923", "ticker": "MYGN", "name": "R. Bryan Riggsbee Chief Financial Officer and Treasurer Interim President and Chief Executive Officer", "position": "", "year": 2018, "salary": 432000, "bonus": 0, "stockAwards": 0, "optionAwards": 254016, "nonEquityIncentiveCompensation": 5366, "changeInPensionValueAndDeferredEarnings": 0, "otherCompensation": 0, "total": 2645582}, {"id": "f97c2a2da0c95385b97ba465bad68615", "cik": "899923", "ticker": "MYGN", "name": "Alexander Ford", "position": "President, Myriad Womens Health, Inc.", "year": 2018, "salary": 499200, "bonus": 0, "stockAwards": 1954200, "optionAwards": 0, "nonEquityIncentiveCompensation": 296525, "otherCompensation": 11020, "total": 2760945}, {"id": "596f5e81466e0c08ab7330a9c2f67f37", "cik": "899923", "ticker": "MYGN", "name": "R. Bryan Riggsbee", "position": "Chief Financial Officer", "year": 2018, "salary": 432000, "bonus": 0, "stockAwards": 1954200, "optionAwards": 0, "nonEquityIncentiveCompensation": 254016, "otherCompensation": 5366, "total": 2645582}, {"id": "73c4554e72a428318e730b823d9713b6", "cik": "899923", "ticker": "MYGN", "name": "R. Bryan Riggsbee", "position": "Chief Financial Officer", "year": 2017, "salary": 432000, "bonus": 307, "stockAwards": 1314000, "optionAwards": 0, "nonEquityIncentiveCompensation": 230688, "otherCompensation": 8174, "total": 1985170}, {"id": "1320dffe72d4fba6a72179829ac13456", "cik": "899923", "ticker": "MYGN", "name": "Mark C. Capone", "position": "President and Chief Executive Officer*", "year": 2017, "salary": 852000, "bonus": 307, "stockAwards": 3613500, "optionAwards": 0, "nonEquityIncentiveCompensation": 741240, "otherCompensation": 10848, "total": 5217895}, {"id": "981f730028b1175587e89cf23b2a9e8a", "cik": "899923", "ticker": "MYGN", "name": "Richard M. Marsh, Esq.", "position": "Executive VP, General Counsel & Secretary", "year": 2017, "salary": 493782, "bonus": 307, "stockAwards": 1095000, "optionAwards": 0, "nonEquityIncentiveCompensation": 222202, "otherCompensation": 10921, "total": 1822212}, {"id": "4098e2d67d09c9b938fad1d095a5401a", "cik": "899923", "ticker": "MYGN", "name": "Alexander Ford", "position": "President, Myriad Genetic Laboratories, Inc.", "year": 2017, "salary": 499200, "bonus": 307, "stockAwards": 1314000, "optionAwards": 0, "nonEquityIncentiveCompensation": 245606, "otherCompensation": 10848, "total": 2069961}, {"id": "162d1242e45949042430389e4d4576a9", "cik": "899923", "ticker": "MYGN", "name": "Jerry S. Lanchbury, Ph.D.", "position": "Chief Scientific Officer", "year": 2017, "salary": 493782, "bonus": 307, "stockAwards": 1095000, "optionAwards": 0, "nonEquityIncentiveCompensation": 214795, "otherCompensation": 10960, "total": 1814844}, {"id": "6344f80d6849f421000ac3760aa581af", "cik": "899923", "ticker": "MYGN", "name": "Jerry S. Lanchbury, Ph.D.", "position": "Chief Scientific Officer", "year": 2016, "salary": 479400, "bonus": 216242, "stockAwards": 1986563, "optionAwards": 0, "nonEquityIncentiveCompensation": 0, "otherCompensation": 11297, "total": 2693502}, {"id": "fd152d51e9e096ca47185570c52b61fd", "cik": "899923", "ticker": "MYGN", "name": "R. Bryan Riggsbee", "position": "Chief Financial Officer", "year": 2016, "salary": 400000, "bonus": 180512, "stockAwards": 2037500, "optionAwards": 0, "nonEquityIncentiveCompensation": 0, "otherCompensation": 10016, "total": 2628028}, {"id": "24565299a0027cc08bb4b714659ca240", "cik": "899923", "ticker": "MYGN", "name": "Richard M. Marsh, Esq.", "position": "Executive VP, General Counsel & Secretary", "year": 2016, "salary": 479400, "bonus": 218639, "stockAwards": 1925438, "optionAwards": 0, "nonEquityIncentiveCompensation": 0, "otherCompensation": 10830, "total": 2634306}, {"id": "3f9be2ddb9e97a5fb908b0b582f96f2b", "cik": "899923", "ticker": "MYGN", "name": "Mark C. Capone", "position": "President and Chief Executive Officer*", "year": 2016, "salary": 800000, "bonus": 512, "stockAwards": 3361875, "optionAwards": 0, "nonEquityIncentiveCompensation": 727200, "otherCompensation": 11048, "total": 4900635}, {"id": "c6e559cb603a1840f639455296ff6653", "cik": "899923", "ticker": "MYGN", "name": "Bernard F. Tobin", "position": "President, Crescendo Bioscience, Inc.", "year": 2016, "salary": 412000, "bonus": 192092, "stockAwards": 2119000, "optionAwards": 0, "nonEquityIncentiveCompensation": 0, "otherCompensation": 11433, "total": 2734525}, {"id": "84f304448534e21a6473ad8e0809b799", "cik": "899923", "ticker": "MYGN", "name": "Peter D. Meldrum", "position": "President and Chief Executive Officer*", "year": 2015, "salary": 1030000, "bonus": 762814, "stockAwards": 9139809, "optionAwards": 10993098, "nonEquityIncentiveCompensation": 97953, "otherCompensation": 1334369, "total": 23358043}, {"id": "b504a734e0398be240b83d287d3d0ee9", "cik": "899923", "ticker": "MYGN", "name": "James S. Evans", "position": "Chief Financial Officer and Treasurer*", "year": 2015, "salary": 163333, "bonus": 0, "stockAwards": 2668400, "optionAwards": 3067842, "nonEquityIncentiveCompensation": 0, "otherCompensation": 490016, "total": 6389591}, {"id": "581cc67a5111cda0d6bf2d9745df29b1", "cik": "899923", "ticker": "MYGN", "name": "Richard M. Marsh, Esq.", "position": "Executive VP, General Counsel & Secretary", "year": 2015, "salary": 470000, "bonus": 174514, "stockAwards": 2401560, "optionAwards": 0, "nonEquityIncentiveCompensation": 33523, "otherCompensation": 10513, "total": 3090110}, {"id": "dae87fd47bf2d0068e5e45cc435d9871", "cik": "899923", "ticker": "MYGN", "name": "Mark C. Capone", "position": "President, Myriad Genetic Laboratories, Inc.*", "year": 2015, "salary": 600000, "bonus": 333614, "stockAwards": 4193200, "optionAwards": 0, "nonEquityIncentiveCompensation": 57060, "otherCompensation": 10248, "total": 5194122}, {"id": "36475182021a8f4ee896d9a51f1ffed0", "cik": "899923", "ticker": "MYGN", "name": "Jerry S. Lanchbury, Ph.D.", "position": "Chief Scientific Officer", "year": 2015, "salary": 470000, "bonus": 174514, "stockAwards": 2477800, "optionAwards": 0, "nonEquityIncentiveCompensation": 33523, "otherCompensation": 10110, "total": 3165947}, {"id": "b14f65f56d9313fd9ef4a7866e1a77a7", "cik": "899923", "ticker": "MYGN", "name": "R. Bryan Riggsbee", "position": "Chief Financial Officer and Treasurer*", "year": 2015, "salary": 265625, "bonus": 129531, "stockAwards": 1050900, "optionAwards": 0, "nonEquityIncentiveCompensation": 0, "otherCompensation": 119623, "total": 1565679}, {"id": "bcdf07ebb21d178a74b49eb2dc086d73", "cik": "899923", "ticker": "MYGN", "name": "Jerry S. Lanchbury, Ph.D.", "position": "Chief Scientific Officer", "year": 2014, "salary": 450824, "bonus": 282819, "stockAwards": 0, "optionAwards": 1844640, "nonEquityIncentiveCompensation": 0, "otherCompensation": 10662, "total": 2588945}, {"id": "e242013218f58edb1931455d3808700f", "cik": "899923", "ticker": "MYGN", "name": "Richard M. Marsh, Esq.", "position": "Executive Vice President, General Counsel and Secretary", "year": 2014, "salary": 457157, "bonus": 276819, "stockAwards": 0, "optionAwards": 1947120, "nonEquityIncentiveCompensation": 0, "otherCompensation": 10515, "total": 2691611}, {"id": "b3bda61f1a5a49fdb73757edf6554ddd", "cik": "899923", "ticker": "MYGN", "name": "Mark C. Capone", "position": "President, Myriad Genetic Laboratories, Inc.", "year": 2014, "salary": 567157, "bonus": 819, "stockAwards": 0, "optionAwards": 3381840, "nonEquityIncentiveCompensation": 552000, "otherCompensation": 10248, "total": 4512064}, {"id": "71c9fed3aabb61e4d4bd3d2b83447941", "cik": "899923", "ticker": "MYGN", "name": "Peter D. Meldrum", "position": "President and Chief Executive Officer", "year": 2014, "salary": 996157, "bonus": 819, "stockAwards": 0, "optionAwards": 5841360, "nonEquityIncentiveCompensation": 1293500, "otherCompensation": 10231, "total": 8142067}, {"id": "ff5ca0c91466fdbcce6412f629bec8c7", "cik": "899923", "ticker": "MYGN", "name": "James S. Evans", "position": "Chief Financial Officer and Treasurer", "year": 2014, "salary": 476157, "bonus": 340819, "stockAwards": 0, "optionAwards": 2152080, "nonEquityIncentiveCompensation": 0, "otherCompensation": 11244, "total": 2980300}, {"id": "167706c18afb3a1bf77e7844330e0a1b", "cik": "899923", "ticker": "MYGN", "name": "James S. Evans", "position": "Chief Financial Officer and Treasurer", "year": 2013, "salary": 459104, "bonus": 327812, "stockAwards": 0, "optionAwards": 1900190, "nonEquityIncentiveCompensation": 0, "otherCompensation": 9702, "total": 2696808}, {"id": "8119d1895a419a6a42c7e91c8ab0e12d", "cik": "899923", "ticker": "MYGN", "name": "Peter D. Meldrum", "position": "President and Chief Executive Officer", "year": 2013, "salary": 956104, "bonus": 812, "stockAwards": 0, "optionAwards": 5200520, "nonEquityIncentiveCompensation": 1241500, "otherCompensation": 15238, "total": 7414174}, {"id": "6eb6f576bee48d9fe4b5613f0cb90e73", "cik": "899923", "ticker": "MYGN", "name": "Jerry S. Lanchbury, Ph.D.", "position": "Chief Scientific Officer", "year": 2013, "salary": 438104, "bonus": 264812, "stockAwards": 0, "optionAwards": 1600160, "nonEquityIncentiveCompensation": 0, "otherCompensation": 10223, "total": 2313299}, {"id": "f8279beb0671b79477bd738c086e1b3a", "cik": "899923", "ticker": "MYGN", "name": "Mark C. Capone", "position": "President, Myriad Genetic Laboratories, Inc.", "year": 2013, "salary": 546104, "bonus": 505812, "stockAwards": 0, "optionAwards": 3000300, "nonEquityIncentiveCompensation": 0, "otherCompensation": 10254, "total": 4062470}, {"id": "b5c3c3918f0c5ced2e58a42f431cdaa5", "cik": "899923", "ticker": "MYGN", "name": "Richard M. Marsh, Esq.", "position": "Executive Vice President, General Counsel and Secretary", "year": 2013, "salary": 443104, "bonus": 273812, "stockAwards": 0, "optionAwards": 1800180, "nonEquityIncentiveCompensation": 0, "otherCompensation": 10377, "total": 2527473}, {"id": "0461298d48608f202b602aa620f4633d", "cik": "899923", "ticker": "MYGN", "name": "Mark C. Capone", "position": "President, Myriad Genetic Laboratories, Inc.", "year": 2012, "salary": 501191, "bonus": 420761, "stockAwards": 0, "optionAwards": 1962548, "nonEquityIncentiveCompensation": 0, "changeInPensionValueAndDeferredEarnings": 0, "otherCompensation": 9857, "total": 2894357}, {"id": "0be06840caef01777812818d873bf6d5", "cik": "899923", "ticker": "MYGN", "name": "James S. Evans", "position": "Chief Financial Officer and Treasurer", "year": 2012, "salary": 440811, "bonus": 290761, "stockAwards": 0, "optionAwards": 1434169, "nonEquityIncentiveCompensation": 0, "changeInPensionValueAndDeferredEarnings": 0, "otherCompensation": 9614, "total": 2175355}, {"id": "aac0d16b79cdb25609c65c928dffdc28", "cik": "899923", "ticker": "MYGN", "name": "Richard M. Marsh, Esq.", "position": "Executive Vice President, General Counsel and Secretary", "year": 2012, "salary": 425811, "bonus": 250761, "stockAwards": 0, "optionAwards": 1358687, "nonEquityIncentiveCompensation": 0, "changeInPensionValueAndDeferredEarnings": 0, "otherCompensation": 10266, "total": 2045525}, {"id": "b5b181964ada4a766f5ab95775464d0a", "cik": "899923", "ticker": "MYGN", "name": "Jerry S. Lanchbury, Ph.D.", "position": "Chief Scientific Officer", "year": 2012, "salary": 420812, "bonus": 244761, "stockAwards": 0, "optionAwards": 1207722, "nonEquityIncentiveCompensation": 0, "changeInPensionValueAndDeferredEarnings": 0, "otherCompensation": 10411, "total": 1883706}, {"id": "33829d03690d5fd04d167650b16fc3aa", "cik": "899923", "ticker": "MYGN", "name": "Peter D. Meldrum", "position": "President and Chief Executive Officer", "year": 2012, "salary": 915812, "bonus": 1100761, "stockAwards": 0, "optionAwards": 3925095, "nonEquityIncentiveCompensation": 0, "changeInPensionValueAndDeferredEarnings": 0, "otherCompensation": 10040, "total": 5951708}, {"id": "1162e43ab4234c72a6135dfa7cf2e45d", "cik": "899923", "ticker": "MYGN", "name": "Peter D. Meldrum", "position": "President and Chief Executive Officer", "year": 2011, "salary": 870504, "bonus": 956312, "stockAwards": 0, "optionAwards": 3029902, "nonEquityIncentiveCompensation": 0, "otherCompensation": 9866, "total": 4866584}, {"id": "83734dae5048fed436d47c83e6a4dec8", "cik": "899923", "ticker": "MYGN", "name": "Mark C. Capone", "position": "President, Myriad Genetic Laboratories, Inc.", "year": 2011, "salary": 455504, "bonus": 334812, "stockAwards": 0, "optionAwards": 1487055, "nonEquityIncentiveCompensation": 0, "otherCompensation": 8316, "total": 2285687}, {"id": "778bc61797dfd474610242456d3feb81", "cik": "899923", "ticker": "MYGN", "name": "James S. Evans", "position": "Chief Financial Officer and Treasurer", "year": 2011, "salary": 420504, "bonus": 251812, "stockAwards": 0, "optionAwards": 1186334, "nonEquityIncentiveCompensation": 0, "otherCompensation": 8316, "total": 1866966}, {"id": "d4353ca02d32894dc7f15c4d6f9a7232", "cik": "899923", "ticker": "MYGN", "name": "Jerry S. Lanchbury, Ph.D.", "position": "Chief Scientific Officer", "year": 2011, "salary": 395504, "bonus": 213812, "stockAwards": 0, "optionAwards": 989163, "nonEquityIncentiveCompensation": 0, "otherCompensation": 10639, "total": 1609118}, {"id": "dcc212e085ebc35f30bb7d5d410162ac", "cik": "899923", "ticker": "MYGN", "name": "Richard M. Marsh, Esq.", "position": "Executive Vice President, General Counsel and Secretary", "year": 2011, "salary": 404504, "bonus": 227812, "stockAwards": 0, "optionAwards": 1120610, "nonEquityIncentiveCompensation": 0, "otherCompensation": 10226, "total": 1763152}, {"id": "13e54439b1d83d8a5223e9b14a9fbc49", "cik": "899923", "ticker": "MYGN", "name": "Mark C. Capone", "position": "President, Myriad Genetic Laboratories, Inc.", "year": 2010, "salary": 396553, "bonus": 178710, "stockAwards": 0, "optionAwards": 1363707, "nonEquityIncentiveCompensation": 0, "changeInPensionValueAndDeferredEarnings": 0, "otherCompensation": 8825, "total": 1947795}, {"id": "3781d77d209a021556f9e2b41be48df8", "cik": "899923", "ticker": "MYGN", "name": "Jerry S. Lanchbury, Ph.D.", "position": "Chief Scientific Officer", "year": 2010, "salary": 352217, "bonus": 150710, "stockAwards": 0, "optionAwards": 1052371, "nonEquityIncentiveCompensation": 0, "changeInPensionValueAndDeferredEarnings": 0, "otherCompensation": 12463, "total": 1567761}, {"id": "7e36d04e9c6f6f2ea420c295b754c19e", "cik": "899923", "ticker": "MYGN", "name": "Gregory C. Critchfield, M.D.", "position": "Former President, Myriad Genetic Laboratories, Inc.", "year": 2010, "salary": 380121, "bonus": 710, "stockAwards": 0, "optionAwards": 1073313, "nonEquityIncentiveCompensation": 0, "changeInPensionValueAndDeferredEarnings": 0, "otherCompensation": 570475, "total": 2024619}, {"id": "6ccb9f83907b2f2c8512dd1e55d8e30f", "cik": "899923", "ticker": "MYGN", "name": "Richard M. Marsh, Esq.", "position": "Executive Vice President, General Counsel and Secretary", "year": 2010, "salary": 385550, "bonus": 154710, "stockAwards": 0, "optionAwards": 1456035, "nonEquityIncentiveCompensation": 0, "changeInPensionValueAndDeferredEarnings": 0, "otherCompensation": 10349, "total": 2006644}, {"id": "d0c3ed891409ad37fb1e9140994d2689", "cik": "899923", "ticker": "MYGN", "name": "Peter D. Meldrum", "position": "President and Chief Executive Officer", "year": 2010, "salary": 832550, "bonus": 649710, "stockAwards": 0, "optionAwards": 3805820, "nonEquityIncentiveCompensation": 0, "changeInPensionValueAndDeferredEarnings": 0, "otherCompensation": 10475, "total": 5298555}, {"id": "82298aaa436ef66018f335611ff72704", "cik": "899923", "ticker": "MYGN", "name": "James S. Evans", "position": "Chief Financial Officer and Treasurer", "year": 2010, "salary": 400550, "bonus": 172710, "stockAwards": 0, "optionAwards": 1614656, "nonEquityIncentiveCompensation": 0, "changeInPensionValueAndDeferredEarnings": 0, "otherCompensation": 8825, "total": 2196741}, {"id": "04fe31bd8ba72580e2b6d3ed8085074c", "cik": "899923", "ticker": "MYGN", "name": "Adrian N. Hobden, Ph.D.", "position": "President, Myriad Pharmaceuticals, Inc.", "year": 2009, "salary": 535552, "bonus": 285812, "stockAwards": 0, "optionAwards": 1237265, "nonEquityIncentiveCompensation": 0, "changeInPensionValueAndDeferredEarnings": 0, "otherCompensation": 9749, "total": 2068378}, {"id": "fd384f4ffa0e0782f05994fa3f05a40b", "cik": "899923", "ticker": "MYGN", "name": "Peter D. Meldrum", "position": "President and Chief Executive Officer", "year": 2009, "salary": 800552, "bonus": 1000812, "stockAwards": 0, "optionAwards": 2250437, "nonEquityIncentiveCompensation": 0, "changeInPensionValueAndDeferredEarnings": 0, "otherCompensation": 9275, "total": 4061076}, {"id": "d6bd7e44dbb8592b4b1629e001681c34", "cik": "899923", "ticker": "MYGN", "name": "Gregory C. Critchfield, M.D.", "position": "President, Myriad Genetic Laboratories, Inc.", "year": 2009, "salary": 551465, "bonus": 415812, "stockAwards": 0, "optionAwards": 1600932, "nonEquityIncentiveCompensation": 0, "changeInPensionValueAndDeferredEarnings": 0, "otherCompensation": 9275, "total": 2577484}, {"id": "96ec73367a13bf31dd34b3fc11dc19da", "cik": "899923", "ticker": "MYGN", "name": "James S. Evans", "position": "Chief Financial Officer and Treasurer", "year": 2009, "salary": 375552, "bonus": 265812, "stockAwards": 0, "optionAwards": 795461, "nonEquityIncentiveCompensation": 0, "changeInPensionValueAndDeferredEarnings": 0, "otherCompensation": 9063, "total": 1445888}, {"id": "d00451172498eeca4b289cafa6508ab5", "cik": "899923", "ticker": "MYGN", "name": "Mark C. Capone", "position": "Chief Operating Officer, Myriad Genetic Laboratories, Inc.", "year": 2009, "salary": 361512, "bonus": 210812, "stockAwards": 0, "optionAwards": 979351, "nonEquityIncentiveCompensation": 0, "changeInPensionValueAndDeferredEarnings": 0, "otherCompensation": 8522, "total": 1560197}, {"id": "325785f56a8dc01c8e332b51d0c92406", "cik": "899923", "ticker": "MYGN", "name": "Richard M. Marsh, Esq.", "position": "Executive Vice President, General Counsel and Secretary", "year": 2009, "salary": 360552, "bonus": 210812, "stockAwards": 0, "optionAwards": 1021605, "nonEquityIncentiveCompensation": 0, "changeInPensionValueAndDeferredEarnings": 0, "otherCompensation": 8489, "total": 1601458}, {"id": "0fca99a888cea88fbc9969266f1fc4fc", "cik": "899923", "ticker": "MYGN", "name": "Peter D. Meldrum", "position": "President and Chief Executive Officer", "year": 2008, "salary": 727552, "bonus": 725812, "stockAwards": 0, "optionAwards": 1029191, "nonEquityIncentiveCompensation": 0, "changeInPensionValueAndDeferredEarnings": 0, "otherCompensation": 9275, "total": 2491830}, {"id": "68d8e9546e3bcb769af06366e7903c74", "cik": "899923", "ticker": "MYGN", "name": "Gregory C. Critchfield, M.D.", "position": "President, Myriad Genetic Laboratories, Inc.", "year": 2008, "salary": 500552, "bonus": 400812, "stockAwards": 0, "optionAwards": 836557, "nonEquityIncentiveCompensation": 0, "changeInPensionValueAndDeferredEarnings": 0, "otherCompensation": 9275, "total": 1747196}, {"id": "b9349f2abc705dbea176a273966ac77a", "cik": "899923", "ticker": "MYGN", "name": "Mark H. Skolnick", "position": "Chief Scientific Officer", "year": 2008, "salary": 411126, "bonus": 150812, "stockAwards": 0, "optionAwards": 567152, "nonEquityIncentiveCompensation": 0, "changeInPensionValueAndDeferredEarnings": 0, "otherCompensation": 9280, "total": 1138370}, {"id": "3840049ba38ff5cc4be65132b83896f1", "cik": "899923", "ticker": "MYGN", "name": "James S. Evans", "position": "Chief Financial Officer", "year": 2008, "salary": 278213, "bonus": 165812, "stockAwards": 0, "optionAwards": 381301, "nonEquityIncentiveCompensation": 0, "changeInPensionValueAndDeferredEarnings": 0, "otherCompensation": 9604, "total": 834930}, {"id": "d3c186d107a6161718622d72e852aa09", "cik": "899923", "ticker": "MYGN", "name": "Adrian N. Hobden, Ph.D.", "position": "President, Myriad Pharmaceuticals, Inc.", "year": 2008, "salary": 500552, "bonus": 400812, "stockAwards": 0, "optionAwards": 798649, "nonEquityIncentiveCompensation": 0, "changeInPensionValueAndDeferredEarnings": 0, "otherCompensation": 9550, "total": 1709563}, {"id": "9e71277e77737addcfca4844587b4514", "cik": "899923", "ticker": "MYGN", "name": "Jay M. Moyes", "position": "Former Chief Financial Officer", "year": 2008, "salary": 128309, "bonus": 0, "stockAwards": 0, "optionAwards": 178923, "nonEquityIncentiveCompensation": 0, "changeInPensionValueAndDeferredEarnings": 0, "otherCompensation": 381329, "total": 688561}, {"id": "7ca45f7b7d61b6080c608daab031e989", "cik": "899923", "ticker": "MYGN", "name": "Peter D. Meldrum", "position": "President and Chief Executive Officer", "year": 2007, "salary": 676978, "bonus": 550761, "stockAwards": 0, "optionAwards": 428543, "nonEquityIncentiveCompensation": 0, "changeInPensionValueAndDeferredEarnings": 0, "otherCompensation": 9084, "total": 1665366}, {"id": "bee43590f328a02f0dbb7f452995bd4f", "cik": "899923", "ticker": "MYGN", "name": "Adrian N. Hobden, Ph.D.", "position": "President, Myriad Pharmaceuticals, Inc.", "year": 2007, "salary": 465478, "bonus": 300761, "stockAwards": 0, "optionAwards": 378292, "nonEquityIncentiveCompensation": 0, "changeInPensionValueAndDeferredEarnings": 0, "otherCompensation": 9440, "total": 1153971}, {"id": "9b932a10c150aa9afdbea36db58e2b38", "cik": "899923", "ticker": "MYGN", "name": "Mark H. Skolnick", "position": "Chief Scientific Officer", "year": 2007, "salary": 377465, "bonus": 150761, "stockAwards": 0, "optionAwards": 279412, "nonEquityIncentiveCompensation": 0, "changeInPensionValueAndDeferredEarnings": 0, "otherCompensation": 9264, "total": 816902}, {"id": "47f0c129d4605a0f52876c4537a5d921", "cik": "899923", "ticker": "MYGN", "name": "Gregory C. Critchfield, M.D.", "position": "President, Myriad Genetic Laboratories, Inc.", "year": 2007, "salary": 465478, "bonus": 350761, "stockAwards": 0, "optionAwards": 378292, "nonEquityIncentiveCompensation": 0, "changeInPensionValueAndDeferredEarnings": 0, "otherCompensation": 9084, "total": 1203615}, {"id": "93fc6a93e9985f4dbe72684ea3f5faf4", "cik": "899923", "ticker": "MYGN", "name": "Jay M. Moyes", "position": "Former Chief Financial Officer", "year": 2007, "salary": 355478, "bonus": 220761, "stockAwards": 0, "optionAwards": 352634, "nonEquityIncentiveCompensation": 0, "changeInPensionValueAndDeferredEarnings": 0, "otherCompensation": 9502, "total": 935375}]